Cargando…
Harnessing the privatisation of China's fragmented health-care delivery
Although China's 2009 health-care reform has made impressive progress in expansion of insurance coverage, much work remains to improve its wasteful health-care delivery. Particularly, the Chinese health-care system faces substantial challenges in its transformation from a profit-driven public h...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7159287/ https://www.ncbi.nlm.nih.gov/pubmed/25176551 http://dx.doi.org/10.1016/S0140-6736(14)61120-X |
_version_ | 1783522633271214080 |
---|---|
author | Yip, Winnie Hsiao, William |
author_facet | Yip, Winnie Hsiao, William |
author_sort | Yip, Winnie |
collection | PubMed |
description | Although China's 2009 health-care reform has made impressive progress in expansion of insurance coverage, much work remains to improve its wasteful health-care delivery. Particularly, the Chinese health-care system faces substantial challenges in its transformation from a profit-driven public hospital-centred system to an integrated primary care-based delivery system that is cost effective and of better quality to respond to the changing population needs. An additional challenge is the government's latest strategy to promote private investment for hospitals. In this Review, we discuss how China's health-care system would perform if hospital privatisation combined with hospital-centred fragmented delivery were to prevail—population health outcomes would suffer; health-care expenditures would escalate, with patients bearing increasing costs; and a two-tiered system would emerge in which access and quality of care are decided by ability to pay. We then propose an alternative pathway that includes the reform of public hospitals to pursue the public interest and be more accountable, with public hospitals as the benchmarks against which private hospitals would have to compete, with performance-based purchasing, and with population-based capitation payment to catalyse coordinated care. Any decision to further expand the for-profit private hospital market should not be made without objective assessment of its effect on China's health-policy goals. |
format | Online Article Text |
id | pubmed-7159287 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71592872020-04-16 Harnessing the privatisation of China's fragmented health-care delivery Yip, Winnie Hsiao, William Lancet Review Although China's 2009 health-care reform has made impressive progress in expansion of insurance coverage, much work remains to improve its wasteful health-care delivery. Particularly, the Chinese health-care system faces substantial challenges in its transformation from a profit-driven public hospital-centred system to an integrated primary care-based delivery system that is cost effective and of better quality to respond to the changing population needs. An additional challenge is the government's latest strategy to promote private investment for hospitals. In this Review, we discuss how China's health-care system would perform if hospital privatisation combined with hospital-centred fragmented delivery were to prevail—population health outcomes would suffer; health-care expenditures would escalate, with patients bearing increasing costs; and a two-tiered system would emerge in which access and quality of care are decided by ability to pay. We then propose an alternative pathway that includes the reform of public hospitals to pursue the public interest and be more accountable, with public hospitals as the benchmarks against which private hospitals would have to compete, with performance-based purchasing, and with population-based capitation payment to catalyse coordinated care. Any decision to further expand the for-profit private hospital market should not be made without objective assessment of its effect on China's health-policy goals. Elsevier Ltd. 2014 2014-08-28 /pmc/articles/PMC7159287/ /pubmed/25176551 http://dx.doi.org/10.1016/S0140-6736(14)61120-X Text en Copyright © 2014 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Review Yip, Winnie Hsiao, William Harnessing the privatisation of China's fragmented health-care delivery |
title | Harnessing the privatisation of China's fragmented health-care delivery |
title_full | Harnessing the privatisation of China's fragmented health-care delivery |
title_fullStr | Harnessing the privatisation of China's fragmented health-care delivery |
title_full_unstemmed | Harnessing the privatisation of China's fragmented health-care delivery |
title_short | Harnessing the privatisation of China's fragmented health-care delivery |
title_sort | harnessing the privatisation of china's fragmented health-care delivery |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7159287/ https://www.ncbi.nlm.nih.gov/pubmed/25176551 http://dx.doi.org/10.1016/S0140-6736(14)61120-X |
work_keys_str_mv | AT yipwinnie harnessingtheprivatisationofchinasfragmentedhealthcaredelivery AT hsiaowilliam harnessingtheprivatisationofchinasfragmentedhealthcaredelivery |